MINNEAPOLIS, Minnesota — November 10, 2025 — Leads & Copy — OneMedNet Corporation (Nasdaq: ONMD) will showcase its next-generation iRWD™ platform at ISPOR Europe, according to a recent press release. The platform is built on the Palantir Technologies Foundry ecosystem and enables life sciences, diagnostics, and medical device organizations to securely generate and analyze regulatory-grade, de-identified real-world data (RWD) through advanced AI-driven analytics.
Earlier this year, OneMedNet advanced its strategy by introducing a recurring revenue model to simplify customer access to high-value RWD, powered by Palantir’s Foundry and AIP. The iRWD™ subscription model features two innovative offerings: Live Data Feeds and AI-Driven Conversational Search. These enhancements convert traditional static data access into dynamic, on-demand intelligence, allowing customers to continuously harness regulatory-grade, multimodal data for real-time insights, accelerated decision-making, and deeper engagement. This approach bolsters OneMedNet’s recurring revenue foundation and has already generated significant market interest.
Live Data Feeds deliver ongoing, real-time streams of de-identified clinical data, enabling organizations to monitor trends, respond to emerging needs, and integrate fresh insights seamlessly into their workflows.
AI-Driven Conversational Search allows users to query complex datasets using natural language. The platform’s deep clinical understanding interprets intent to build precise cohorts without requiring rigid search strings, which democratizes data access, reduces technical barriers, and accelerates innovation by making sophisticated analytics intuitive and efficient.
According to research from Strategy&, a PwC brand, the AI-enabled market presents an estimated US$868 billion opportunity by 2030. However, a key challenge persists in securing high-quality, timely, de-identified clinical multimodal data. OneMedNet’s recent announcement of its selection to utilize Palantir’s platforms noted that “responsible access to healthcare data remains a key barrier” to unlocking this crucial opportunity.
According to Aaron Green, President and CEO of OneMedNet, Palantir’s Foundry and AIP platform supercharge OneMedNet’s ability to deliver regulatory-grade, multimodal RWD with speed, consistency, traceability, and security. Green added that the iRWD™ platform marks a significant leap forward in how life sciences and AI innovators discover, access, and operationalize real-world data from vast clinical datasets, and will transform the clinical data acquisition landscape.
OneMedNet is transforming how the world unlocks Real-World Data (RWD), by harnessing the potential of over 1,750 healthcare sites through its iRWD™ platform. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that redefine patient care and power the next wave of healthcare disruption. OneMedNet’s proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking possibilities by testing production system upgrades, de-risking complex projects, and sharing sensitive data after stripping out personal information.
Contact:
Michael Wong, VP Marketing
Email: michael.wong@onemednet.com
Source: OneMedNet Corporation
